Results

Janssen Biotech Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 13:10

U.S. FDA Approves DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or[...]